Literature DB >> 26868684

Potent P2Y12 Inhibitors in Low-Risk Patients: Is There a Medical Need?

Johanne Silvain1, Mathieu Kerneis1, Gilles Montalescot2.   

Abstract

Entities:  

Keywords:  acute coronary syndrome; coronary artery disease; percutaneous coronary intervention; platelet aggregation inhibitors; prasugrel hydrochloride

Mesh：

Substances：

Year:  2016        PMID： 26868684     DOI： 10.1016/j.jacc.2015.11.043

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  1 in total

1.  Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009-2016.

Authors:  Elias J Dayoub; Ashwin S Nathan; Sameed Ahmed M Khatana; Matthew Seigerman; Sony Tuteja; Taisei Kobayashi; Daniel M Kolansky; Peter W Groeneveld; Jay Giri
Journal:  Circ Cardiovasc Interv       Date:  2019-01       Impact factor: 6.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.